Skip to main content
Year archive

Marksans Pharma Ltd. — 2026 filings

All 50 regulatory filings released by Marksans Pharma Ltd. (MARKSANS) in 2026, sourced directly from the official regulator.

50 Filings
2026 Period
2026 filings (50)
Filing Released Lang
India Ratings and Research has revised the outlook for the Company''s bank loan facilities to Positive from Stable
Regulatory Filings
2026-06-09 English
Credit Rating- Revision
Regulatory Filings
2026-06-09 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-06-08 English
Intimation of schedule for Virtual Investors Conference
Regulatory Filings
2026-06-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2026-06-03 English
Marksans Pharma Limited submits Transcripts of Investors/Analyst meet on Q4 FY 26 Audited Financial Results
Call Transcript
2026-06-03 English
Copy of Newspaper Publication
Regulatory Filings
2026-06-03 English
Newspaper Publication regarding Second 100 day Campaign- "Saksham Niveshak"
Regulatory Filings
2026-06-03 English
General Updates
Regulatory Filings
2026-06-02 English
Campaign for KYC and other related updations and shareholders engagement to prevent transfer of unclaimed dividend to IEPF
Regulatory Filings
2026-06-02 English
Press Release
M&A Activity
2026-06-01 English
Press Release titled Marksans Pharma Ltd. to acquire 100 percent of Netherland based QliniQ B.V., strengthening presence in European Markets
M&A Activity
2026-06-01 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-05-27 English
Audio Recording of investor(s) / analyst(s) meet Conference Call on Q4 FY26 Financial Results
Regulatory Filings
2026-05-27 English
Copy of Newspaper Publication
Earnings Release FY 2026
2026-05-27 English
Newspaper publication of Audited Financial Results for the financial year ended 31 March, 2026
Report Publication Announcement
2026-05-27 English
ASCR under Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year 31, March 2026
Regulatory Filings
2026-05-27 English
The Board has recommended Dividend of Rs. 0.90 per share subject to approval of Shareholders at ensuing Annual General Meeting
Regulatory Filings
2026-05-26 English
Press Release
Earnings Release FY 2026
2026-05-26 English
Marksans Pharma Limited Press Release on Q4 FY26 Results
Earnings Release FY 2026
2026-05-26 English
Investor Presentation
Investor Presentation
2026-05-26 English
Investors Presentation Q4 FY26
Investor Presentation
2026-05-26 English
Dividend
Audit Report / Information FY 2026
2026-05-26 English
Audited Financial Results for the quarter and year ended 31 March, 2026
Interim / Quarterly Report FY 2026
2026-05-26 English
Outcome of Board Meeting
Audit Report / Information FY 2026
2026-05-26 English
Outcome of Board Meeting held on 26 May, 2026
Interim / Quarterly Report FY 2026
2026-05-26 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2026-05-25 English
Intimation of Grant of stock options under Marksans Employee Stock Option Scheme 2024
Regulatory Filings
2026-05-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2026-05-19 English
The Company has scheduled a conference call for analysts and investors on Wednesday, May 27, 2026 at 04:30 PM (IST) to discuss the Audited Financial Results (Standalone and Consolidated) ....
Regulatory Filings
2026-05-19 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2026-05-19 English
Marksans Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve Audited Standalone and Consolidated ....
Board/Management Information
2026-05-12 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2026-04-09 English
Press Release
Regulatory Filings
2026-04-01 English
Trading Window
Regulatory Filings
2026-03-26 English
Copy of Newspaper Publication
Regulatory Filings
2026-03-12 English
General Updates
Regulatory Filings
2026-03-11 English
General Updates
Regulatory Filings
2026-03-10 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2026-02-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-02-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-02-06 English
Copy of Newspaper Publication
Earnings Release 9M 2026
2026-02-06 English
Press Release
Earnings Release 9M 2026
2026-02-05 English
Investor Presentation
Investor Presentation
2026-02-05 English
Outcome of Board Meeting
Regulatory Filings
2026-02-05 English
General Updates
Capital/Financing Update
2026-01-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-01-22 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2026-01-13 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-01-09 English
Board Meeting — Financial Results
Board/Management Information
2026-01-09 English